These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7916390)

  • 1. Expression of P-glycoprotein in de novo acute myelogenous leukemia at initial diagnosis: results of molecular and functional assays, and correlation with treatment outcome.
    Ino T; Miyazaki H; Isogai M; Nomura T; Tsuzuki M; Tsuruo T; Ezaki K; Hirano M
    Leukemia; 1994 Sep; 8(9):1492-7. PubMed ID: 7916390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia.
    Ludescher C; Eisterer W; Hilbe W; Gotwald M; Hofmann J; Zabernigg A; Cianfriglia M; Thaler J
    Leukemia; 1995 Feb; 9(2):350-6. PubMed ID: 7869774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
    Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
    Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-glycoprotein expression in adult acute myeloid leukemia: correlation with induction treatment outcome.
    Tóthová E; Elbertová A; Fricová M; Kafková A; Hlebasková M; Svorcová E; Stecová N; Guman T; Raffac S
    Neoplasma; 2001; 48(5):393-7. PubMed ID: 11845985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cell lines.
    Bailly JD; Muller C; Jaffrézou JP; Demur C; Gassar G; Bordier C; Laurent G
    Leukemia; 1995 May; 9(5):799-807. PubMed ID: 7769842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay.
    Lamy T; Drenou B; Grulois I; Fardel O; Jacquelinet C; Goasguen J; Dauriac C; Amiot L; Bernard M; Fauchet R
    Leukemia; 1995 Sep; 9(9):1549-55. PubMed ID: 7658724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-glycoprotein expression and prognostic value in acute myeloid leukemia.
    Senent L; Jarque I; Martín G; Sempere A; González-García Y; Gomis F; Pérez-Sirvent M; De La Rubia J; Sanz MA
    Haematologica; 1998 Sep; 83(9):783-7. PubMed ID: 9825574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program.
    Willman CL
    Semin Hematol; 1997 Oct; 34(4 Suppl 5):25-33. PubMed ID: 9408958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved flow-cytometric detection of low P-glycoprotein expression in leukaemic blasts by histogram subtraction analysis.
    Müller MR; Lennartz K; Nowrousian MR; Dux R; Tsuruo T; Rajewsky MF; Seeber S
    Cytometry; 1994 Jan; 15(1):64-72. PubMed ID: 7512893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistant cells with high proliferative capacity determine response to therapy in acute myeloid leukemia.
    te Boekhorst PA; Löwenberg B; van Kapel J; Nooter K; Sonneveld P
    Leukemia; 1995 Jun; 9(6):1025-31. PubMed ID: 7541095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.
    Filipits M; Suchomel RW; Zöchbauer S; Brunner R; Lechner K; Pirker R
    Clin Cancer Res; 1997 Aug; 3(8):1419-25. PubMed ID: 9815827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.
    Li GY; Liu JZ; Zhang B; Wang LX; Wang CB; Chen SG
    Biomed Pharmacother; 2009 Sep; 63(8):566-70. PubMed ID: 19095404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
    Maslak P; Hegewisch-Becker S; Godfrey L; Andreeff M
    Cytometry; 1994 Sep; 17(1):84-93. PubMed ID: 8001461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model.
    Iwahashi T; Okochi E; Ariyoshi K; Watabe H; Amann E; Mori S; Tsuruo T; Ono K
    Cancer Res; 1993 Nov; 53(22):5475-82. PubMed ID: 8106147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-Glycoprotein Expression in Acute Myeloid Leukaemia Cells at Diagnosis: Its relationship to Daunorubicin or Idarubicin Induction Therapy and Survival; Malignancy.
    Pogliani EM; Carpenedo M; Miccolis I; Belotti D; Corneo GM
    Hematology; 2001; 5(5):359-367. PubMed ID: 11399635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione system, topoisomerase II level and multidrug resistance phenotype in acute myelogenous leukemia before treatment and at relapse.
    Massaad-Massade L; Ribrag V; Marie JP; Faussat AM; Bayle C; Dreyfus F; Gouyette A
    Anticancer Res; 1997; 17(6D):4647-51. PubMed ID: 9494583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine.
    Gerrard G; Payne E; Baker RJ; Jones DT; Potter M; Prentice HG; Ethell M; McCullough H; Burgess M; Mehta AB; Ganeshaguru K
    Haematologica; 2004 Jul; 89(7):782-90. PubMed ID: 15257929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of mdr1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods.
    Zhou DC; Marie JP; Suberville AM; Zittoun R
    Leukemia; 1992 Sep; 6(9):879-85. PubMed ID: 1355575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein expression and in vitro reversion of doxorubicin resistance by verapamil in clinical specimens from acute leukaemia and myeloma.
    Solary E; Bidan JM; Calvo F; Chauffert B; Caillot D; Mugneret F; Gauville C; Tsuruo T; Carli PM; Guy H
    Leukemia; 1991 Jul; 5(7):592-7. PubMed ID: 1677057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the multidrug resistance P glycoprotein in newly diagnosed adult acute lymphoblastic leukemia: absence of correlation with response to treatment.
    Wattel E; Lepelley P; Merlat A; Sartiaux C; Bauters F; Jouet JP; Fenaux P
    Leukemia; 1995 Nov; 9(11):1870-4. PubMed ID: 7475277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.